HK1044290A1 - X射線引導的藥物輸送 - Google Patents
X射線引導的藥物輸送Info
- Publication number
- HK1044290A1 HK1044290A1 HK02105951.4A HK02105951A HK1044290A1 HK 1044290 A1 HK1044290 A1 HK 1044290A1 HK 02105951 A HK02105951 A HK 02105951A HK 1044290 A1 HK1044290 A1 HK 1044290A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- drug delivery
- ray guided
- guided drug
- ray
- delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1203—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules in a form not provided for by groups A61K51/1206 - A61K51/1296, e.g. cells, cell fragments, viruses, virus capsides, ghosts, red blood cells, viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Dispersion Chemistry (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Radiation-Therapy Devices (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/302,456 US6159443A (en) | 1999-04-29 | 1999-04-29 | X-ray guided drug delivery |
PCT/US2000/011485 WO2000066182A1 (en) | 1999-04-29 | 2000-04-28 | X-ray guided drug delivery |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1044290A1 true HK1044290A1 (zh) | 2002-10-18 |
Family
ID=23167805
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK02105951.4A HK1044290A1 (zh) | 1999-04-29 | 2002-08-14 | X射線引導的藥物輸送 |
Country Status (7)
Country | Link |
---|---|
US (1) | US6159443A (zh) |
EP (1) | EP1194173A4 (zh) |
JP (1) | JP2002543164A (zh) |
AU (1) | AU776899B2 (zh) |
CA (1) | CA2368748A1 (zh) |
HK (1) | HK1044290A1 (zh) |
WO (1) | WO2000066182A1 (zh) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7049140B1 (en) * | 1999-04-29 | 2006-05-23 | Vanderbilt University | X-ray guided drug delivery |
JP2001022865A (ja) * | 1999-07-06 | 2001-01-26 | Canon Inc | 画像処理装置、画像処理システム、画像処理方法、及び記憶媒体 |
US6989153B2 (en) * | 1999-11-30 | 2006-01-24 | Varian Medical Systems Technologies, Inc. | Radiation sensitive liposomes |
US7597878B2 (en) * | 2000-09-19 | 2009-10-06 | Li-Cor, Inc. | Optical fluorescent imaging |
WO2002030456A1 (en) * | 2000-10-12 | 2002-04-18 | The University Of Tennessee Research Corporation | Targeting drug/gene carriers to irradiated tissue |
US20100215786A9 (en) * | 2000-12-05 | 2010-08-26 | Jensen Claude Jarkae | Morinda citrifolia enhanced lip treatment |
US6702744B2 (en) | 2001-06-20 | 2004-03-09 | Advanced Cardiovascular Systems, Inc. | Agents that stimulate therapeutic angiogenesis and techniques and devices that enable their delivery |
US7306925B2 (en) * | 2001-11-09 | 2007-12-11 | Vanderbilt University | Phage antibodies to radiation-inducible neoantigens |
US8101157B2 (en) * | 2001-10-03 | 2012-01-24 | Vanderbilt University | Ligands to radiation-induced molecules |
US7906102B2 (en) * | 2001-10-03 | 2011-03-15 | Vanderbilt University | Ligands to radiation-induced molecules |
AU2002330139A1 (en) * | 2001-10-03 | 2003-04-14 | Vanderbilt University | In vivo panning for ligands to radiation-induced molecules |
US8608661B1 (en) | 2001-11-30 | 2013-12-17 | Advanced Cardiovascular Systems, Inc. | Method for intravascular delivery of a treatment agent beyond a blood vessel wall |
US7635463B2 (en) * | 2002-02-27 | 2009-12-22 | Pharmain Corporation | Compositions for delivery of therapeutics and other materials |
US7361368B2 (en) | 2002-06-28 | 2008-04-22 | Advanced Cardiovascular Systems, Inc. | Device and method for combining a treatment agent and a gel |
ES2443416T3 (es) | 2002-07-18 | 2014-02-19 | Helix Biopharma Corp. | Uso de ureasa para inhibir el crecimiento de células cancerosas |
AU2003259846A1 (en) * | 2002-08-16 | 2004-03-03 | The General Hospital Corporation | Non-invasive functional imaging of peripheral nervous system activation in humans and animals |
KR20050111583A (ko) * | 2003-02-06 | 2005-11-25 | 각고호우징 게이오기주크 | 펩티드 결합체 |
US8038991B1 (en) | 2003-04-15 | 2011-10-18 | Abbott Cardiovascular Systems Inc. | High-viscosity hyaluronic acid compositions to treat myocardial conditions |
US8821473B2 (en) | 2003-04-15 | 2014-09-02 | Abbott Cardiovascular Systems Inc. | Methods and compositions to treat myocardial conditions |
US7641643B2 (en) | 2003-04-15 | 2010-01-05 | Abbott Cardiovascular Systems Inc. | Methods and compositions to treat myocardial conditions |
WO2004099215A1 (ja) | 2003-05-09 | 2004-11-18 | Keio University | ビンカアルカロイドおよびその塩の利用 |
WO2005018682A2 (en) | 2003-08-20 | 2005-03-03 | The Regents Of The University Of California | Somatostatin analogs with inhibitory activity to growth hormone release |
EP3242318A1 (en) | 2003-12-19 | 2017-11-08 | The University of North Carolina at Chapel Hill | Monodisperse micro-structure or nano-structure product |
WO2006028993A2 (en) * | 2004-09-02 | 2006-03-16 | Vanderbilt University | Assessment of cancer susceptibility to molecular targeted therapy by use of recombinant peptides |
US7854944B2 (en) | 2004-12-17 | 2010-12-21 | Advanced Cardiovascular Systems, Inc. | Tissue regeneration |
US20080125745A1 (en) | 2005-04-19 | 2008-05-29 | Shubhayu Basu | Methods and compositions for treating post-cardial infarction damage |
US8828433B2 (en) | 2005-04-19 | 2014-09-09 | Advanced Cardiovascular Systems, Inc. | Hydrogel bioscaffoldings and biomedical device coatings |
US8187621B2 (en) | 2005-04-19 | 2012-05-29 | Advanced Cardiovascular Systems, Inc. | Methods and compositions for treating post-myocardial infarction damage |
US8303972B2 (en) | 2005-04-19 | 2012-11-06 | Advanced Cardiovascular Systems, Inc. | Hydrogel bioscaffoldings and biomedical device coatings |
US9539410B2 (en) | 2005-04-19 | 2017-01-10 | Abbott Cardiovascular Systems Inc. | Methods and compositions for treating post-cardial infarction damage |
WO2007003010A1 (en) * | 2005-07-05 | 2007-01-11 | Baker Medical Research Institute | Anticoagulation agent and uses thereof |
JP2007210957A (ja) * | 2006-02-10 | 2007-08-23 | Chiba Univ | 腫瘍の放射線療法における放射線治療増強剤 |
US7732190B2 (en) | 2006-07-31 | 2010-06-08 | Advanced Cardiovascular Systems, Inc. | Modified two-component gelation systems, methods of use and methods of manufacture |
US9242005B1 (en) | 2006-08-21 | 2016-01-26 | Abbott Cardiovascular Systems Inc. | Pro-healing agent formulation compositions, methods and treatments |
US8741326B2 (en) | 2006-11-17 | 2014-06-03 | Abbott Cardiovascular Systems Inc. | Modified two-component gelation systems, methods of use and methods of manufacture |
US9005672B2 (en) | 2006-11-17 | 2015-04-14 | Abbott Cardiovascular Systems Inc. | Methods of modifying myocardial infarction expansion |
US8192760B2 (en) | 2006-12-04 | 2012-06-05 | Abbott Cardiovascular Systems Inc. | Methods and compositions for treating tissue using silk proteins |
US8372427B2 (en) * | 2007-03-05 | 2013-02-12 | Abbott Cardiovascular Systems Inc. | Therapeutic composition with enhanced endothelium targeting |
US8435490B2 (en) * | 2007-06-21 | 2013-05-07 | The Johns Hopkins University | Small peptides specifically bind to colorectal cancers |
EP2173430A4 (en) * | 2007-07-30 | 2012-11-21 | Univ Loma Linda Med | SYSTEMS AND METHOD FOR THE PARTICULAR RADIATION INCREASED ADMINISTRATION OF THERAPY |
WO2009121055A1 (en) * | 2008-03-28 | 2009-10-01 | Georgia Tech Research Corporation | Reduced dye probes for the detection of radical oxygen species |
US20100209341A1 (en) * | 2009-02-18 | 2010-08-19 | Csl Limited | Treatment of chronic inflammatory conditions |
WO2010114901A1 (en) | 2009-03-31 | 2010-10-07 | The Board Of Trustees Of The University Of Arkansas | Method of controlled drug release from a liposome carrier |
US8269197B2 (en) | 2009-07-22 | 2012-09-18 | Intraop Medical Corporation | Method and system for electron beam applications |
EA201290846A1 (ru) * | 2010-03-01 | 2013-07-30 | Интраоп Медикал Корпорейшн | Лучевая терапия, комбинированная с сенсибилизаторами гипоксической клетки |
SG184224A1 (en) * | 2010-03-24 | 2012-11-29 | Univ Singapore | Development of photostable near-ir cyanine dyes for in vivo imaging |
WO2011137514A1 (en) * | 2010-05-03 | 2011-11-10 | University Health Network | Imageable activatable agent for radiation therapy and method and system for radiation therapy |
US8368453B2 (en) * | 2011-05-25 | 2013-02-05 | Analog Devices, Inc. | Switch circuits |
WO2013019730A1 (en) | 2011-07-29 | 2013-02-07 | The Washington University | Antibodies to tip-1 and grp78 |
US9849087B2 (en) | 2011-11-08 | 2017-12-26 | The Board Of Trustees Of The University Of Arkansas | Methods and compositions for X-ray induced release from pH sensitive liposomes |
US20160136211A1 (en) * | 2013-06-17 | 2016-05-19 | Viralytics Limited | Methods for the treatment of bladder cancer |
EP3172222A4 (en) | 2014-07-24 | 2018-03-21 | Washington University | Compositions targeting radiation-induced molecules and methods of use thereof |
WO2016024279A1 (en) * | 2014-08-13 | 2016-02-18 | Convergent R.N.R Ltd | Means and methods for targeted x-ray therapy |
WO2017219029A2 (en) | 2016-06-17 | 2017-12-21 | Magenta Therapeutics, Inc. | Compositions and methods for the depletion of cd117+cells |
SG10202102897PA (en) | 2017-01-20 | 2021-04-29 | Magenta Therapeutics Inc | Compositions and methods for the depletion of cd137+ cells |
WO2018148595A1 (en) | 2017-02-10 | 2018-08-16 | Washington University | Antibodies to tip1 and methods of use thereof |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1534956A (en) * | 1975-05-15 | 1978-12-06 | Ermans A | Method of labeling proteins with technetium |
US4515165A (en) * | 1980-02-04 | 1985-05-07 | Energy Conversion Devices, Inc. | Apparatus and method for detecting tumors |
US4670386A (en) * | 1980-05-23 | 1987-06-02 | Stephen Sugaar | Cancer tests using tumor antigen generated lymphokines and compositions |
JPS6058927A (ja) * | 1983-09-09 | 1985-04-05 | Nippon Mejifuijitsukusu Kk | 放射能標識血小板製剤 |
US4820505A (en) * | 1985-04-04 | 1989-04-11 | Scripps Clinic And Research Foundation | Detection of activated platelets with antibodies to thrombospondin |
GB8601003D0 (en) * | 1986-01-16 | 1986-02-19 | Amersham Int Plc | Labelling blood cells |
US5328840A (en) * | 1989-08-15 | 1994-07-12 | The Research Foundation Of The State University Of New York | Method for preparing targeted carrier erythrocytes |
US5093104A (en) * | 1989-08-17 | 1992-03-03 | Syncor International Corporation | Method for labelling leucocytes with indium in-111 oxine |
US5382680A (en) * | 1990-12-07 | 1995-01-17 | The Center For Innovative Technology | Allosteric hemoglobin modifier compounds |
US5830856A (en) * | 1991-02-08 | 1998-11-03 | Diatide, Inc. | Radiolabeled compounds for thrombus imaging |
US5334369A (en) * | 1991-06-11 | 1994-08-02 | Medical University Of South Carolina | Platelet receptor antagonists useful in detecting intravascular platelet aggregation |
US5292524A (en) * | 1991-09-06 | 1994-03-08 | California Institute Of Technology | Blood platelet loaded with diagnostic or therapeutic-containing liposome or reconstituted Sendai virus |
AU2773792A (en) * | 1991-10-03 | 1993-05-03 | Dana-Farber Cancer Institute, Inc. | Leukocyte adhesion molecule-1 (lam-1) and ligand thereof |
WO1993014791A2 (en) * | 1992-01-27 | 1993-08-05 | Cryopharm Corporation | Method of inactivation of viral and bacterial blood contaminants |
JP3353209B2 (ja) * | 1992-04-03 | 2002-12-03 | ジェネンテク,インコーポレイテッド | αvβ3インテグリンに対する抗体 |
US5565491A (en) * | 1994-01-31 | 1996-10-15 | Bristol-Myers Squibb Company | Use of phosphotyrosine phospatase inhibitors for controlling cellular proliferation |
US5759542A (en) * | 1994-08-05 | 1998-06-02 | New England Deaconess Hospital Corporation | Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases |
US5516881A (en) * | 1994-08-10 | 1996-05-14 | Cornell Research Foundation, Inc. | Aminoxyl-containing radical spin labeling in polymers and copolymers |
BR9507579A (pt) * | 1994-10-25 | 1997-09-09 | Watson Clinic Foundation | Processo fluorométrico para medir ativaçao de plaqueta endógena em amostra de plaquetas |
US5962424A (en) * | 1995-02-21 | 1999-10-05 | Arch Development Corporation | Methods and compositions for targeting selectins |
-
1999
- 1999-04-29 US US09/302,456 patent/US6159443A/en not_active Expired - Lifetime
-
2000
- 2000-04-28 CA CA002368748A patent/CA2368748A1/en not_active Abandoned
- 2000-04-28 EP EP00935839A patent/EP1194173A4/en not_active Withdrawn
- 2000-04-28 JP JP2000615065A patent/JP2002543164A/ja active Pending
- 2000-04-28 WO PCT/US2000/011485 patent/WO2000066182A1/en active IP Right Grant
- 2000-04-28 AU AU51239/00A patent/AU776899B2/en not_active Ceased
-
2002
- 2002-08-14 HK HK02105951.4A patent/HK1044290A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2000066182A1 (en) | 2000-11-09 |
AU776899B2 (en) | 2004-09-23 |
CA2368748A1 (en) | 2000-11-09 |
AU5123900A (en) | 2000-11-17 |
EP1194173A4 (en) | 2003-05-14 |
US6159443A (en) | 2000-12-12 |
EP1194173A1 (en) | 2002-04-10 |
JP2002543164A (ja) | 2002-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1044290A1 (zh) | X射線引導的藥物輸送 | |
HK1072177A1 (en) | Drug delivery device | |
HK1079718A1 (en) | Intracardiac drug delivery | |
IL149224A0 (en) | Hydrogen-driven drug dosage form | |
IL137650A0 (en) | Drug delivery devices | |
NZ513700A (en) | Oral drug delivery system | |
EP1068874A4 (en) | MEDICINE DISPENSING DEVICE IN THE FORM OF AN INHALATOR | |
HUP0104901A3 (en) | Medicament dispenser | |
EP1062962A4 (en) | INHALATION TYPE DRUG DISPENSER | |
GB9924780D0 (en) | Medicament dispenser | |
EP1061987A4 (en) | DEVICE FOR ADMINISTERING A MEDICINAL PRODUCT | |
GB2355252B (en) | Improvements in drug delivery devices | |
EG23858A (en) | Drug combination | |
GB9809933D0 (en) | Drug delivery device | |
AU6503399A (en) | Drug delivery catheter | |
GB9930160D0 (en) | Drug delivery | |
GB9904304D0 (en) | Drug delivery | |
GB9917737D0 (en) | Multiple therapy drug delivery | |
GB9900965D0 (en) | Inhaled drug delivery | |
GB9917470D0 (en) | Medicament delivery system | |
GB9905134D0 (en) | Medicament delivery system | |
GB9923273D0 (en) | Medicament delivery system | |
GB9804768D0 (en) | Drug delivery | |
GB9816436D0 (en) | Multiple therapy drug delivery | |
GB9901133D0 (en) | Drug delivery system |